1260 related articles for article (PubMed ID: 33546704)
1. The cancer metabolic reprogramming and immune response.
Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.
Katopodi T; Petanidis S; Anestakis D; Charalampidis C; Chatziprodromidou I; Floros G; Eskitzis P; Zarogoulidis P; Koulouris C; Sevva C; Papadopoulos K; Dagher M; Karakousis VA; Varsamis N; Theodorou V; Mystakidou CM; Vlassopoulos K; Kosmidis S; Katsios NI; Farmakis K; Kosmidis C
Front Immunol; 2023; 14():1325360. PubMed ID: 38292487
[TBL] [Abstract][Full Text] [Related]
3. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.
Dai E; Zhu Z; Wahed S; Qu Z; Storkus WJ; Guo ZS
Mol Cancer; 2021 Dec; 20(1):171. PubMed ID: 34930302
[TBL] [Abstract][Full Text] [Related]
5. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
Pacella I; Piconese S
Front Immunol; 2019; 10():1889. PubMed ID: 31507585
[TBL] [Abstract][Full Text] [Related]
6. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
7. The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity.
Wu Z; Li S; Zhu X
Front Immunol; 2021; 12():682435. PubMed ID: 34194437
[TBL] [Abstract][Full Text] [Related]
8. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.
Li X; Wenes M; Romero P; Huang SC; Fendt SM; Ho PC
Nat Rev Clin Oncol; 2019 Jul; 16(7):425-441. PubMed ID: 30914826
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
[TBL] [Abstract][Full Text] [Related]
11. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
Wu D
Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
[TBL] [Abstract][Full Text] [Related]
12. Lactate in the tumour microenvironment: From immune modulation to therapy.
Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
[TBL] [Abstract][Full Text] [Related]
13. Interplay between Immune Checkpoint Proteins and Cellular Metabolism.
Lim S; Phillips JB; Madeira da Silva L; Zhou M; Fodstad O; Owen LB; Tan M
Cancer Res; 2017 Mar; 77(6):1245-1249. PubMed ID: 28246276
[TBL] [Abstract][Full Text] [Related]
14. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy.
Guerra L; Bonetti L; Brenner D
Cell Rep; 2020 Jul; 32(1):107848. PubMed ID: 32640218
[TBL] [Abstract][Full Text] [Related]
16. Proteoglycans and Immunobiology of Cancer-Therapeutic Implications.
Tzanakakis G; Neagu M; Tsatsakis A; Nikitovic D
Front Immunol; 2019; 10():875. PubMed ID: 31068944
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
18. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38811773
[TBL] [Abstract][Full Text] [Related]
19. Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.
Traba J; Sack MN; Waldmann TA; Anton OM
Front Immunol; 2021; 12():657293. PubMed ID: 34079545
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Reprogramming in Immune Response and Tissue Inflammation.
Sun (孙李哲) L; Yang (杨晓峰) X; Yuan (袁祖贻) Z; Wang (王虹) H
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1990-2001. PubMed ID: 32698683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
